This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Agios Pharmaceuticals, Inc., Celgene Corporation. Active years: 2020.
IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurie A Kenvin. Retrieved from https://idiyas.com/inventor/laurie-a-kenvin
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
USPTO Granted Patents = 2 (Patent Applications = 3)
% Patents Active = 100.0
EPO Patents = 1 (Patent Applications = 1)
Average Co-Inventor Count = 8.0
ph-index = 2
Forward Citations = 6(Granted Patents)
Company Filing History:
2 out of 99 
Agios Pharmaceuticals, Inc.
2 out of 561 
Celgene Corporation
where one patent can have more than one assignee
Years Active: 2020
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents pending:
IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurie A Kenvin. Retrieved from https://idiyas.com/inventor/laurie-a-kenvin
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent pending (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent pending (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]